A-shares closed · 港股休市 Quotes 行情 · 25 Sep 17:19 CST
28 Sep 2026 · 01:37 CST Terminal Access 终端入口 →
300039.SZ深圳证券交易所 · 创业板 ChiNext

Shanghai Kaibao Pharmaceutical 上海凯宝

Traditional Chinese Medicine 中药Ⅱ
¥5.21+¥0.01 · +0.19%Delayed 行情延迟 · 24 Sep 2026 · 16:14 CST · CNY
Open 开盘
¥5.22
High 最高
¥5.30
Low 最低
¥5.15
Prev Close 昨收
¥5.20
Volume 成交量
2,339.3万股
Turnover 成交额
¥1.22亿
Mkt Cap 总市值
¥54亿
P/E 市盈率
21.1×
Recent Activity 近期动态All Filings 全部公告 →

5 significant filings since 31 May 2026: 2 on regulatory action and 3 on major holder buying. The latest, on 30 Jun 2026: 关于对上海证监局行政监管措施决定的整改报告. 1 unverified report logged, the latest on 5 Jun 2026.
自 31 May 2026 起有 5 份重大公告:regulatory action 2 份、major holder buying 3 份。最新一份(30 Jun 2026):关于对上海证监局行政监管措施决定的整改报告。记录了 1 条未经核实的报道,最新一条见于 5 Jun 2026。

Price History 价格走势

1 session 个交易日, Thu 24 Sep 2026 · Live one-minute prices · High 最高 ¥5.30 · Low 最低 ¥5.16 · +0.19% on the previous close of ¥5.20
5.1755.2005.2255.2505.2755.300
Volume 成交量
1.6万
09:3010:3011:3014:0015:00

Against Its Own History 与自身历史比较

21.1×
Median 中值 17.8× · Range 区间 17.2× to 23.8× · 7 periods 期
1.27×
Median 中值 1.53× · Range 区间 1.04× to 1.73× · 10 periods 期

Period by Period 逐期

Period 报告期Close at Period End 期末收盘TTM EPS 滚动每股收益 BPS 每股净资产
30 Jun 2026 中报¥4.26¥0.2517.2×¥4.101.04×
31 Mar 2026 一季报¥5.89¥0.2523.8×¥4.471.32×
31 Dec 2025 年报¥6.03¥0.2722.6×¥4.221.43×
30 Sep 2025 三季报¥6.07¥0.3318.4×¥4.351.40×
30 Jun 2025 中报¥6.06¥0.3417.8×¥4.081.49×
31 Mar 2025 一季报¥6.32¥0.3617.8×¥4.021.57×
31 Dec 2024 年报¥6.18¥0.3617.2×¥3.921.58×
30 Sep 2024 三季报¥6.39——¥3.681.73×
30 Jun 2024 中报¥5.35——¥3.361.59×
31 Mar 2024 一季报¥6.12——¥3.611.69×

Consensus Forward EPS 机构预测每股收益

No broker forecasts for this company yet 暂无机构预测

Not Computed 未计算
  • Dividend Yield 股息率
  • Free Cash Flow 自由现金流
  • EV/EBITDA